Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Luxbright AB is a pioneering technology company focused on advancing the field of X-ray imaging technology. Specializing in the development and manufacturing of innovative X-ray tubes and components, Luxbright AB aims to enhance and transform the capabilities of medical diagnostics, industrial inspection, and scientific research. The primary function of its technology is to provide clearer, more precise imaging, thereby improving the accuracy and efficiency of various applications across these sectors. Luxbright AB's products are designed to be more energy-efficient and cost-effective compared to traditional X-ray technologies, which is crucial for both sustainability and affordability. By introducing these advanced solutions, Luxbright AB significantly impacts industries such as healthcare, where accurate imaging is critical for diagnosis and treatment planning, and in industrial settings where precise inspection can prevent equipment failures and improve safety. Headquartered in Sweden, Luxbright AB continues to play a vital role in the X-ray imaging market by pushing the boundaries of what is technically possible, influencing both current industry practices and future technological advancements.
kr 0.01
+kr 0.00 (+0.00%)
Live · 08:36 PM · Twelve Data
The business is unprofitable at the operating level (-169.07% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 26.5% YoY with margins expanding 34.9pp.
ROIC dropped from -42.54% to -47.21%, capital efficiency is deteriorating. Negative free cash flow of -kr 20M. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
kr 11M
▲ +26.5% YoY
Net Income (TTM)
-kr 19M
▼ -9.9% YoY
Op. Margin
-169.07%
▲ +34.9pp YoY
ROIC
-47.21%
▼ -4.7pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-kr 20M
▼ -20.3% YoY
Op. Cash Flow (TTM)
-kr 19M
▼ -17.9% YoY
Net Debt
-kr 2M
Net Cash Position
Cash & Equiv.
kr 5M
Continue Research
Luxbright AB (LXB.XSTO)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Luxbright AB scores 10/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Luxbright AB scores 10 out of 100 on Intrinsiqq's quality score, passing 1 of 4 checks, which makes it a lower-quality business on these measures. Recent fundamentals include a -169.1% operating margin and a -47.2% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full check-by-check breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh LXB.XSTO's valuation and scores 10/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.